Boardroom Alpha
Meeting calendar
ANF · Annual meeting · Wednesday, June 3, 2026

Abercrombie & Fitch Co

9 nominees · 3 ballot items.

Elect nine directors; advisory vote to approve Fiscal 2025 named executive officer compensation (Say on Pay); ratify PricewaterhouseCoopers LLP as independent registered public accounting firm for Fiscal 2026.

Market cap
$4.2B
1Y TSR
-2.2%
Board grade
C+
Record date
Apr 6, 2026
Filing
DEF 14A
Meeting concluded · Jun 3, 2026

Follow how the vote landed and what changed on Abercrombie & Fitch Co’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect nine director nominees to serve until the 2027 Annual Meeting of Stockholders.

  2. 2

    Advisory Vote to Approve Fiscal 2025 Named Executive Officer Compensation (Say on Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve Fiscal 2025 compensation of named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal seeks a non-binding, advisory approval of the Company's Fiscal 2025 named executive officer compensation as disclosed in the proxy statement. Management requests shareholder endorsement of its compensation philosophy and execution, pointing to pay-for-performance design elements: majority of NEO pay is at risk, annual cash incentives tied to Adjusted EBIT and Constant Currency Net Sales, and PSAs tied to three-year average Net Sales growth, Adjusted EBIT margin, and Relative TSR. The Compensation Committee applied discretion in Fiscal 2025 — notably excluding tariff expenses and certain litigation items from Adjusted EBIT in the annual cash incentive calculations — which substantially increased annual payouts after adjustment; this discretionary treatment is explained as a response to unanticipated tariffs and litigation items largely deemed outside management’s control. The Board recommends a “FOR” vote, emphasizing strong historical stockholder support (98% approval in 2025), prudent governance features (clawbacks, stock ownership guidelines, independent compensation consultant), and overall alignment between pay and multi-year performance. Voting is advisory; the Board and Compensation Committee will consider results when setting future compensation but are not bound by the outcome.

  3. 3

    Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for Fiscal 2026

    ManagementBoard: FOR

    Ratify the appointment of PwC as the Company's independent registered public accounting firm for Fiscal 2026.

Director elections

Nominees on the ballot9

Independent
Tenure on this board
8.4 yrs
Also a director at
Labcorp Holdings Inc (LH)Worthington Enterprises Inc (WOR)Sherwin Williams Co (SHW)
Independent
Tenure on this board
6.2 yrs
Also a director at
Fossil Group Inc (FOSL)
Independent
Tenure on this board
6.2 yrs
Also a director at
Build-a-bear Workshop Inc (BBW)
Independent
Tenure on this board
7.5 yrs
Also a director at
Signet Jewelers Ltd (SIG)
Independent
Tenure on this board
2.7 yrs
Also a director at
Estee Lauder Companies Inc (EL)
Independent
Tenure on this board
5.5 yrs
Also a director at
Occidental Petroleum Corp (OXY)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.7.9%3,510,305$321M
2AQR CAPITAL MANAGEMENT LLC7.7%3,422,839$309M
3VANGUARD PORTFOLIO MANAGEMENT LLC5.4%2,416,161$221M
4VANGUARD CAPITAL MANAGEMENT LLC4.6%2,052,413$188M
5STATE STREET CORP4.0%1,770,236$162M
6BBFIT INVESTMENTS PTE LTD3.7%1,632,944$149M
7AMERICAN CENTURY COMPANIES INC3.7%1,622,227$148M
8BlackRock, Inc.3.6%1,606,689$147M
9DIMENSIONAL FUND ADVISORS LP3.3%1,452,628$133M
10ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.9%1,310,296$120M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Abercrombie & Fitch Co 2026 annual meeting?
Abercrombie & Fitch Co (ANF) holds its 2026 annual shareholder meeting on Wednesday, June 3, 2026.
What is the record date for the Abercrombie & Fitch Co 2026 meeting?
The record date for the Abercrombie & Fitch Co 2026 meeting is Monday, April 6, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Abercrombie & Fitch Co's 2026 meeting?
The board is presenting 9 director nominees at the Abercrombie & Fitch Co 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Abercrombie & Fitch Co 2026 meeting?
Shareholders will vote on 3 proposals at the Abercrombie & Fitch Co 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer